{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T17:11:23Z","timestamp":1759425083685,"version":"build-2065373602"},"reference-count":77,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2010,5,23]],"date-time":"2010-05-23T00:00:00Z","timestamp":1274572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis Care &amp;amp; Research"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1002\/acr.20260","type":"journal-article","created":{"date-parts":[[2010,5,26]],"date-time":"2010-05-26T11:21:51Z","timestamp":1274872911000},"page":"1174-1180","source":"Crossref","is-referenced-by-count":4,"title":["New pharmacologic approaches in the management of osteoarthritis"],"prefix":"10.1002","volume":"62","author":[{"given":"Thomas J.","family":"Schnitzer","sequence":"first","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2010,8,3]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2007.12.013"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004257.pub2"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2008.09.018"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2002.tb04234.x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-4-199508150-00001"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.03.011"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2009.01.014"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.332.7553.1302"},{"key":"e_1_2_7_10_2","first-page":"313","article-title":"Clinical research in OA: the NIH Osteoarthritis Initiative","volume":"8","author":"Lester G","year":"2008","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2008.07.011"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2009.06.006"},{"key":"e_1_2_7_13_2","first-page":"242","article-title":"DMOAD developments: present and future","volume":"65","author":"Pelletier JP","year":"2007","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2003.12.012"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.2174\/187152708783885174"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-1878(199802)20:2<137::AID-BIES6>3.0.CO;2-Q"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.1994.tb00581.x"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.1996.0039"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(94)90366-2"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2009.11.022"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022475432077"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199911000-00002"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(01)01597-7"},{"key":"e_1_2_7_24_2","first-page":"4989","article-title":"Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients","volume":"17","author":"Jacobs BL","year":"2010","journal-title":"Can J Urol"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.04652.x"},{"key":"e_1_2_7_26_2","first-page":"237","article-title":"Efficacy and safety of PF04383119 in treating moderate to severe pain due to osteoarthritis (OA)","volume":"67","author":"Lane NE","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_7_27_2","first-page":"S312","article-title":"Long\u2010term tanezumab use for treatment of moderate to severe osteoarthritic knee pain: an open\u2010label extension study","volume":"60","author":"Lane NE","year":"2009","journal-title":"Arthritis Rheum"},{"key":"e_1_2_7_28_2","unstructured":"National Institutes of Health. Tanezumab search. URL:http:\/\/clinicaltrials.gov\/ct2\/results?term=tanezumab."},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.24120"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/0470867639.ch2"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/0470867639.ch17"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22460"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-4-47"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.24837"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-009-1203-2"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-8-29"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e3282f41d7e"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2009.06.024"},{"key":"e_1_2_7_39_2","first-page":"S50","article-title":"Duloxetine 60\u2013120 mg once daily versus placebo in the treatment of patients with osteoarthritis knee pain","volume":"10","author":"Chappell AS","year":"2009","journal-title":"Pain Med"},{"key":"e_1_2_7_40_2","first-page":"543","article-title":"Tramadol for osteoarthritis: a systematic review and metaanalysis","volume":"34","author":"Cepeda MS","year":"2007","journal-title":"J Rheumatol"},{"key":"e_1_2_7_41_2","unstructured":"National Institutes of Health. Duloxetine search. URL:http:\/\/clinicaltrials.gov\/ct2\/results?term=duloxetine."},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.12.4.365"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328330e89a"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2009.03.005"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.9304"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar2465"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-009-1801-1"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2009.01.001"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.57.12.0004"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2009.12.013"},{"key":"e_1_2_7_51_2","first-page":"S318","article-title":"26\u2010week efficacy and safety evaluation of naproxcinod, a first\u2010in\u2010class cyclooxygenase inhibiting nitric oxide donator (CINOD), in patients with osteoarthritis of the knee","volume":"60","author":"Marrero CE","year":"2009","journal-title":"Arthritis Rheum"},{"key":"e_1_2_7_52_2","unstructured":"National Institutes of Health. Naproxcinod search. URL:http:\/\/www.clinicaltrials.gov\/ct2\/results?term=naproxcinod."},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520510024197"},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.11.1537"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.023572"},{"key":"e_1_2_7_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2009.05.014"},{"key":"e_1_2_7_57_2","first-page":"S888","article-title":"Differential blood pressure effect of naproxcinod compared with naproxen on ambulatory blood pressure in hypertensive subjects","volume":"118","author":"Townsend R","year":"2008","journal-title":"Circulation"},{"key":"e_1_2_7_58_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000149684.01903.b8"},{"key":"e_1_2_7_59_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.115"},{"key":"e_1_2_7_60_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta11510"},{"key":"e_1_2_7_61_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002296"},{"key":"e_1_2_7_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04090.x"},{"key":"e_1_2_7_63_2","unstructured":"National Institutes of Health. PN400 search. URL:http:\/\/clinicaltrials.gov\/ct2\/results?term=PN400."},{"issue":"3","key":"e_1_2_7_64_2","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.14309\/00000434-200910003-00126","article-title":"PN400 significantly improves upper gastrointestinal tolerability compared with enteric\u2010coated naproxen alone in patients requiring chronic NSAID therapy: results from two prospective, randomized, controlled trials","volume":"104","author":"Goldstein J","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_7_65_2","first-page":"S314","article-title":"PN400 significantly reduces the incidence of gastric ulcers compared with enteric\u2010coated naproxen in patients requiring chronic NSAID therapy regardless of low\u2010dose aspirin use: results from two prospective, randomized controlled trials","volume":"60","author":"Goldstein JL","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"3","key":"e_1_2_7_66_2","first-page":"704","article-title":"Significant reduction in upper gastrointestinal (UGI) ulcers with HZT\u2010501, a single\u2010tablet combination of ibuprofen\u2010famotidine, the REDUCE 1 and 2 trials","volume":"68","author":"Weinblatt ME","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_7_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16893-1"},{"key":"e_1_2_7_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2009.04.014"},{"key":"e_1_2_7_69_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.21258"},{"key":"e_1_2_7_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(02)00715-9"},{"key":"e_1_2_7_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2006.03.014"},{"key":"e_1_2_7_72_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1402.041"},{"key":"e_1_2_7_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2009.08.004"},{"key":"e_1_2_7_74_2","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-200822030-00001"},{"key":"e_1_2_7_75_2","unstructured":"National Institutes of Health. Calcitonin search. URL:http:\/\/clinicaltrials.gov\/ct2\/results?term=calcitonin."},{"key":"e_1_2_7_76_2","doi-asserted-by":"publisher","DOI":"10.1080\/03009740701483014"},{"key":"e_1_2_7_77_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar2463"},{"key":"e_1_2_7_78_2","unstructured":"National Institutes of Health. SD\u20106010 search. URL:http:\/\/clinicaltrials.gov\/ct2\/results?term=sd\u20106010."}],"container-title":["Arthritis Care &amp; Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Facr.20260","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acr.20260","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T16:28:16Z","timestamp":1759422496000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/acr.20260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":77,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.1002\/acr.20260"],"URL":"https:\/\/doi.org\/10.1002\/acr.20260","archive":["Portico"],"relation":{},"ISSN":["2151-464X","2151-4658"],"issn-type":[{"type":"print","value":"2151-464X"},{"type":"electronic","value":"2151-4658"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}